ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
2 hedge funds and large institutions have $228K invested in Avenue Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$219K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$9K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $219K | 27,500 | +27,500 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $9K | 1,090 | +1,090 | New |
|